» Authors » M V Ezhov

M V Ezhov

Explore the profile of M V Ezhov including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 42
Citations 48
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Nasonova S, Meshkov A, Zhirov I, Osmolovskaya Y, Shoshina A, Gagloev A, et al.
Ter Arkh . 2024 Oct; 96(9):901-908. PMID: 39467245
Dilated cardiomyopathy (DCM) is a leading cause of heart failure, sudden cardiac death, and heart transplantation in young patients. The causes of DCM are varied and include genetic factors and...
2.
Benimetskaya K, Provatorov S, Ezhov M, Krivosheev Y, Gavrilko A, Uranov A, et al.
Kardiologiia . 2023 Dec; 63(11):46-56. PMID: 38088112
Aim      To evaluate prescription of lipid-lowering and antithrombotic therapy in clinical practice and to compare differences in recommendations using the clinical decision support service (CDSS).Material and methods  Electronic medical records...
3.
Pogosova N, Ezhov M, Barinova I, Ausheva A, Kuchiev D, Popova A, et al.
Kardiologiia . 2023 Nov; 63(10):63-71. PMID: 37970857
Aim: To evaluate the relationship between the in-hospital mortality of patients with COVID-19 and the history of cardiovascular disease (CVD) using data from the Russian registry of patients with COVID-19....
4.
Mareev Y, Ezhov M, Villevalde S, Alieva A, Obrezan A, Tarasov A, et al.
Kardiologiia . 2023 Mar; 63(2):11-18. PMID: 36880138
This Expert Council focuses on the meta-analysis of studies on the risk of atrial fibrillation (AF) in patients taking omega-3 polyunsaturated fatty acids (PUFA) and of data on the omega-3...
5.
Klesareva E, Afanasieva O, Sherstyuk E, Tmoyan N, Razova O, Tyurina A, et al.
Ter Arkh . 2022 Oct; 94(4):479-484. PMID: 36286796
Background: Hyperlipoproteinemia (a) is an independent and cause risk factor for atherosclerotic cardiovascular diseases (ASCVD). The correlation between lipoprotein (a) Lp(a) and inflammation in the vessel wall was actively studied...
6.
Voevoda M, Gurevich V, Ezhov M, Sergienko I
Kardiologiia . 2022 Jul; 62(6):57-62. PMID: 35834343
Inclisiran is a novel hypolipidemic drug that inhibits synthesis of the PCSK9 protein through the process called RNA interference. Inclisiran is a double-stranded, modified RNA bound to the N-acetylgalactosamine (GalNAc)...
7.
Boytsov S, Pogosova N, Paleev F, Ezhov M, Komarov A, Pevsner D, et al.
Kardiologiia . 2021 Mar; 61(2):4-14. PMID: 33734042
Aim      To evaluate the clinical picture and factors associated with unfavorable outcomes in admitted patients with COVID-19.Material and methods This study included all patients admitted to the COVID Center of...
8.
Vozniuk I, Shamalov N, Ezhov M, Tikhomirova O, Gurevich V, Kucherenko S, et al.
Zh Nevrol Psikhiatr Im S S Korsakova . 2020 Jul; 120(6):152-161. PMID: 32678563
Hyperlipidemia is the main risk factor for diseases caused by atherosclerosis including ischemic stroke. This publication provides practical recommendations and an algorithm for prescribing lipid-lowering therapy to post-ischemic stroke patients....
9.
Tmoyan N, Ezhov M, Afanasieva O, Klesareva E, Afanasieva M, Balakhonova T, et al.
Zh Nevrol Psikhiatr Im S S Korsakova . 2020 Apr; 120(3. Vyp. 2):42-48. PMID: 32307429
Introduction: Lipoprotein(a) [Lp(a)] is a genetically determined risk factor of coronary heart disease and its complications. Meanwhile data about the role of Lp(a) in development of ischemic stroke are controversial....
10.
Tmoyan N, Afanasieva O, Ezhov M, Klesareva E, Afanasieva M, Razova O, et al.
Kardiologiia . 2019 Dec; 59(12):20-27. PMID: 31849309
Аim. Comparative assessment of respiratory indicators according to multifunctional monitoring (PFM) with the recommended standard for a complete polysomnographic study and an assessment of the effect of blood pressure (BP)...